SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Polyrizon Completes Enrollment of 120 Patients in US NASARIX Allergy Study

Polyrizon completed enrollment of 120 patients in its US NASARIX allergy study.

PLRZ

Related stories